Pricing Log in Create free account

Nautilus Biotechnology, Inc. (NAUT) vs Turn Therapeutics Inc. (TTRX)

Nautilus Biotechnology, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Turn Therapeutics Inc. are of similar size ($273.9M and $273.0M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 6 and Turn Therapeutics Inc. on 4.

Valuation

Metric NAUT TTRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.43 403.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (20.76%) (3.12%) (32.88%)
Free cash flow yield (19.43%) (1.61%) (23.13%)

Profitability

Metric NAUT TTRX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) (3,315.33%) (51.96%)
Return on assets (33.49%) (99.59%) (46.06%)
Return on invested capital (133.48%) 0.00% 0.00%

Growth

Metric NAUT TTRX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 16.07% (80.72%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NAUT TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 9.25 1.19 4.97
Net debt to EBITDA 1.67 0.96 1.01

Dividend

Metric NAUT TTRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NAUT TTRX Biotechnology median
Market cap 273.85m 272.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack